April 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreMay 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreApril 21, 2026
According to market projections, the single cell sequencing sector is expected to grow from USD 1.63 billion in 2024 to USD 6.65 billion by 2034, reflecting a CAGR of 15.05%. Advancements in sequencing technologies and increased funding for personalized medicine are further driving its expansion....
April 21, 2026
The U.S. residual DNA testing market is growing because increasing application of this testing in forensics and criminal investigations, immigration, infidelity, and paternity....
April 21, 2026
Based on market forecasts, the residual DNA testing sector will expand from USD 310 million in 2024 to USD 552.93 million by 2034, experiencing a CAGR of 5.96%. The residual DNA testing market is rising due to strict regulations to ensure patient safety. North America dominates the market due to the presence of strong regulatory organizations....
April 21, 2026
Market insights predict, the digital PCR (dPCR) and real-time PCR (qPCR) industry is expected to grow from USD 10.15 billion in 2024 to USD 21.87 billion by 2034, driven by a CAGR of 7.97%. The digital PCR (dPCR) and real-time PCR (qPCR) market is growing due to rising demand for gene sequencing and the development of gene therapies. North America ...
April 21, 2026
Based on market forecasts, the DNA methylation sector will expand from USD 2.05 billion in 2025 to USD 7.36 billion by 2035, experiencing a CAGR of 13.64%. The emerging trend of genomic imprinting and gene expression regulation drives the importance of DNA methylation. North America dominated the market in 2024 owing to the robust research and deve...
April 21, 2026
Market insights predict the global cell and gene therapy isolator industry will increase from USD 1.35 billion in 2024 to USD 4.47 billion by 2034, achieving a CAGR of 12.54%. The growing demand for cell and gene therapy products and technological advancements drive the market. North America dominated the global market due to the presence of key pl...
April 21, 2026
Market insights predict, the cell and gene overexpression service industry is expected to grow from USD 771.40 million in 2024 to USD 1,192.24 million by 2034, driven by a CAGR of 4.45%. The cell and gene overexpression service market is expanding due to growing demand for biologics as well as growth in plasmid-based transfection use. North America...
April 21, 2026
Projections indicate that, the global cell & gene therapy (CGT) biomanufacturing market will increase from USD 14.03 billion in 2024 to USD 41.41 billion by 2034, experiencing a CAGR of 11.43% over the next 10 years. Increasing outsourcing & contract manufacturing have driven the growth of the market. North America led the global market owi...
April 21, 2026
Market insights predict, the gene knockdown stable cell line service industry is expected to grow from USD 715 million in 2024 to USD 1557 million by 2034, driven by a CAGR of 8.16%. The market is growing due to the increasing use of stable cell models in drug development, target validation, and functional genomics studies. The strong biotech resea...
April 21, 2026
Based on market forecasts, the global cell and gene therapy tools and reagents market, projected at USD 10.04 billion in 2024, is expected to reach USD 27.3 billion by 2034, growing at a CAGR of 10.76% over the forecast period. The cell and gene therapy tools and reagents market is expanding due to growing CGT clinical trials as well as growing res...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
